U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

The company has looked internally for its new leader, as Doustdar is currently serving as its head of international ...

Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its ...

Danish pharma giant Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

Shares in Novo Nordisk plunged as much as 30% after the Danish drugmaker cut its guidance as U.S. sales continue to be hurt by copycat versions of its blockbuster Wegovy weight-loss drug.

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

Novo Nordisk A/S promoted its head of international operations to become its new chief executive officer after a profit ...

Novo Nordisk stock fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its ...

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk warned on Tuesday that full-year sales and operating profit would grow ...

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth ...